Othello Syndrome in Parkinson’s Disease - a review of etiology, diagnosis and management
DOI:
https://doi.org/10.12775/QS.2025.46.66677Keywords
Othello syndrome, Parkinson’s disease, delusional jealousy, dopamine agonist therapyAbstract
Introduction: Othello syndrome, also known as delusional jealousy, is a rare subtype of delusional disorder characterized by a persistent, unfounded belief in a partner's infidelity. Although classically associated with psychiatric disorders, OS is increasingly recognized in the context of neurological diseases, particularly Parkinson’s disease. This review explores the epidemiology, pathogenesis, symptomatology, and treatment of OS, with emphasis on its manifestation in PD patients.
Materials and Methods: This narrative review examines recent research on OS, focusing on its presentation in PD and current treatment approaches. Sources include studies from 2021-2024 identified via PubMed database, along with DSM-5 and ICD-10 guidelines.
Results: The prevalence of OS ranges from 0.5-1.4% in psychiatric populations and up to 15.8% in individuals with major neurocognitive disorders, including PD. In PD, delusional jealousy is the second most common type of delusion after persecutory delusions and is most commonly linked to dopamine agonist therapy rather than PD dementia. Neuroimaging studies suggest dysfunction in the frontal-limbic circuitry, especially in the right prefrontal cortex, contributes to the development of OS. Symptoms include fixed delusions of infidelity, compulsive behaviours, emotional dysregulation, and occasionally, visual hallucinations. These often result in interpersonal conflict, aggression, and increased risk of suicide and homicide.
Conclusions: Management of OS in PD is complex and often requires modification of dopaminergic treatment. Reducing or discontinuing dopamine agonists may alleviate symptoms but can exacerbate motor dysfunction. Atypical antipsychotics, mood stabilizers, and SSRIs have shown benefit. Recognition of OS is crucial, as its impact on patient quality of life and interpersonal relationships can be profound. Early diagnosis and individualized treatment are essential to prevent escalation to violence or psychiatric crises.
References
1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V), 2013, American Psychiatric Publishing
2. Morimoto K, Miyatake R, Nakamura M, Watanabe T, Hirao T, Suwaki H. Delusional disorder: molecular genetic evidence for dopamine psychosis. Neuropsychopharmacology. 2002;26(6):794-801.
doi:10.1016/S0893-133X(01)00421-3
3. Park JH, Sarwar S, Hassett LC, Staab JP, Fipps DC. Clinical Characterization, Course, and Treatment of Othello Syndrome: A Case Series and Systematic Review of the Literature. J Acad Consult Liaison Psychiatry. 2024;65(1):89-105. doi:https://doi.org/10.1016/j.jaclp.2023.09.006
4. De Michele G, Palmieri GR, Pane C, et al. Othello syndrome in Parkinson's disease: a systematic review and report of a case series. Neurol Sci. 2021;42(7):2721-2729. doi:https://doi.org/10.1007/s10072-021-05249-4
5. El Otmani H, Sabiry S, Bellakhdar S, El Moutawakil B, Abdoh Rafai M. Othello syndrome in Parkinson's disease: A diagnostic emergency of an underestimated condition. Rev Neurol (Paris). 2021;177(6):690-693. doi:https://doi.org/10.1016/j.neurol.2020.08.006
6. Béreau M, Fleury V, Bouthour W, Castrioto A, Lhommée E, Krack P. Hyperdopaminergic behavioral spectrum in Parkinson's disease: A review. Rev Neurol (Paris). 2018;174(9):653-663.
doi:https://doi.org/10.1016/j.neurol.2018.07.005
7. Nagano-Saito A, Washimi Y, Arahata Y, et al. Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology. 2005;64(2):224-229. doi:https://doi.org/10.1212/01.WNL.0000149510.41793.50
8. Luauté JP, Saladini O, Luauté J. Neuroimaging correlates of chronic delusional jealousy after right cerebral infarction. J Neuropsychiatry Clin Neurosci. 2008;20(2):245-247.
doi:https://doi.org/10.1176/jnp.2008.20.2.245
9. Graff-Radford J, Whitwell JL, Geda YE, Josephs KA. Clinical and imaging features of Othello's syndrome. Eur J Neurol. 2012;19(1):38-46. doi:https://doi.org/10.1111/j.1468-1331.2011.03412.x
10. Fénelon G, Alves G. Epidemiology of psychosis in Parkinson's disease. J Neurol Sci. 2010;289(1-2):12-17.
doi:https://doi.org/10.1016/j.jns.2009.08.014
11. Cipriani G, Vedovello M, Nuti A, di Fiorino A. Dangerous passion: Othello syndrome and dementia. Psychiatry Clin Neurosci. 2012;66(6):467-473. doi:https://doi.org/10.1111/j.1440-1819.2012.02386.x
12. Easton CJ, Swan S, Sinha R. Prevalence of family violence in clients entering substance abuse treatment. J Subst Abuse Treat. 2000;18(1):23-28. doi:https://doi.org/10.1016/S0740-5472(99)00019-7
13. Czerwiak KZ, Cyrkler M, Drabik A, Soroka E. Dangerous Intersection of Alcoholism and Othello Syndrome: A Comprehensive Review of Delusional Jealousy and Treatment Strategies. Med Sci Monit. 2024;30:e945616. Published 2024 Sep 12. doi:10.12659/MSM.945616
14. Foley JA, Chen C, Paget A, Cipolotti L. A Bayesian predictive processing account of Othello syndrome in Parkinson's disease. Cogn Neuropsychiatry. 2023;28(4):269-284. doi:https://doi.org/10.1080/13546805.2023.2229080
15. Silva AJ, Ferrari MM, Leong GB, Penny G. The dangerousness of persons with delusional jealousy. J Am Acad Psychiatry Law. 1998;26(4):607-623.
16. Pal K, Smith A, Hayes J, Chakraborty A. Othello syndrome secondary to ropinirole: a case study. Case Rep Psychiatry. 2012;2012:353021. doi:https://doi.org/10.1155/2012/353021
17. Papagiouvannis G, Theodosis-Nobelos P, Rekka EA. A Review on Therapeutic Strategies against Parkinson's Disease: Current Trends and Future Perspectives. Mini Rev Med Chem. 2025;25(2):96-111.
doi:10.2174/0113895575303788240606054620
18. Kataoka H, Sugie K. Delusional Jealousy (Othello Syndrome) in 67 Patients with Parkinson's Disease. Front Neurol. 2018;9:129. Published 2018 Mar 7. doi:10.3389/fneur.2018.00129
19. Adam RJ, McLeod R, Ha AD, et al. Resolution of Othello Syndrome After Subthalamic Nucleus Deep Brain Stimulation in 3 Patients with Parkinson's Disease. Mov Disord Clin Pract. 2014;1(4):357-360. Published 2014 Sep 16. doi:10.1002/mdc3.12084
20. Van Schependom J, D'haeseleer M. Advances in Neurodegenerative Diseases. J Clin Med. 2023;12(5):1709. Published 2023 Feb 21.
doi:10.3390/jcm12051709
21. Zheng X, Kendrick KM. Neural and Molecular Contributions to Pathological Jealousy and a Potential Therapeutic Role for Intranasal Oxytocin. Front Pharmacol. 2021;12:652473. Published 2021 Apr 20.
doi:10.3389/fphar.2021.652473
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Karolina Bury, Karolina Koguc, Karolina Kusibab, Julita Bartoszek

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 66
Number of citations: 0